Johns A
Department of Forensic Psychiatry, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK.
Br J Psychiatry. 2001 Feb;178:116-22. doi: 10.1192/bjp.178.2.116.
Cannabis is commonly regarded as an innocuous drug and the prevalence of lifetime and regular use has increased in most developed countries. However, accumulative evidence highlights the risks of dependence and other adverse effects, particularly among people with pre-existing psychiatric disorders.
To re-evaluate the adverse effects of cannabis in the general population and among vulnerable individuals, including those with serious psychiatric disorders.
A wide-ranging review of the topics related to these issues. Results and conclusions An appreciable proportion of cannabis users report short-lived adverse effects, including psychotic states following heavy consumption, and regular users are at risk of dependence. People with major mental illnesses such as schizophrenia are especially vulnerable in that cannabis generally provokes relapse and aggravates existing symptoms. Health workers need to recognise, and respond to, the adverse effects of cannabis on mental health.
大麻通常被视为一种无害药物,在大多数发达国家,终生使用和经常使用大麻的比例有所上升。然而,越来越多的证据凸显了大麻依赖及其他不良反应的风险,尤其是在已有精神疾病的人群中。
重新评估大麻在普通人群以及包括患有严重精神疾病者在内的易受伤害个体中的不良反应。
对与这些问题相关的主题进行广泛综述。结果与结论相当一部分大麻使用者报告有短期不良反应,包括大量吸食后出现的精神状态异常,且经常使用者有依赖风险。患有精神分裂症等严重精神疾病的人尤其易受影响,因为大麻通常会引发复发并加重现有症状。卫生工作者需要认识到大麻对心理健康的不良影响并做出应对。